Business

FDA Decides on Peptide Compounding

Updated 2026-07-23 13:25 UTC 1 source Neutral

The FDA is considering whether to allow the legal compounding of seven peptides, including BPC-157 and TB-500. This decision could significantly impact their availability in the U.S.

Coverage timeline — 1 article

MarketWatch

The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.

2026-07-23 13:18 UTC